We are live on ! Find out more

266 hedge funds and large institutions have $2.73B invested in RXO in 2025 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 101 increasing their positions, 76 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 76

2.95% more ownership

Funds ownership: 105.43%108.38% (+3%)

1% more capital invested

Capital invested by funds: $2.72B → $2.73B (+$17M)

0% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 40

1% less funds holding

Funds holding: 268266 (-2)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

89% less call options, than puts

Call options by funds: $1.75M | Put options by funds: $15.7M

Holders
266
Holders Change
-2
Holders Change %
-0.75%
% of All Funds
3.48%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
40
Increased
101
Reduced
76
Closed
40
Calls
$1.75M
Puts
$15.7M
Net Calls
-$13.9M
Net Calls Change
+$16.1M

RXO Hedge Fund Activity: Q3 2025 in Review

266 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in RXO (RXO) for Q3 2025, worth a combined $2.73B — up 0.63% from $2.72B a quarter earlier.

Fund positioning in RXO was balanced in Q3 2025: 40 funds opened new positions, 40 closed out, 101 added to existing stakes and 76 trimmed.

The largest buyer was Finepoint Capital, opening a new position worth an estimated $117M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $36.2M sold.

  • 266 institutional investors held RXO (RXO) as of Q3 2025, down from 268 in Q2 2025.
  • Funds reported $2.73B of RXO stock for Q3 2025, up 0.63% quarter-over-quarter.
  • 40 funds opened new RXO positions in Q3 2025 and 40 closed out, a net change of 0 holders.
  • The largest RXO buyer in Q3 2025 was Finepoint Capital, an estimated $117M added.
  • The largest RXO seller in Q3 2025 was T. Rowe Price Investment Management, an estimated $36.2M sold.

Based on aggregated 13F filings for Q3 2025.